Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature-Reference-Cited by-同舟云学术

Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature

Published:2018 Issue:2 Volume:57 Page:253-258
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Higashi Yoshitsugu¹,Nakamura Shigeki²,Tsuji Yasuhiro³,Ogami Chika³,Matsumoto Kaoru¹,Kawago Koyomi¹,Tokui Kotaro⁴,Hayashi Ryuji⁴,Sakamaki Ippei¹,Yamamoto Yoshihiro¹

Affiliation:

1. Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan

2. Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Japan

3. Department of Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Japan

4. First Department of Internal Medicine, University of Toyama, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/2/57_9010-17/_pdf

Reference31 articles.

1. 1. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47: 2538-2544, 2003.

2. 2. Fowler VG Jr, Boucher HW, Corey R, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355: 653-665, 2006.

3. 3. Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI. Daptomycin 98-01 and 99-01 Investigators. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38: 1673-1681, 2004.

4. 4. Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S. Eosinophilic pneumonia in patients treated with daptomycin: Review of the literature and US FDA adverse event reporting system reports. Drug Saf 35: 447-457, 2012.

5. 5. Package insert. Cubicin (daptomycin) Injection, Cubist Pharmaceuticals, Lexington, MA: November 2010.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between age and onset of daptomycin-induced adverse events using the U.S. food and drug administration adverse event reporting system;Journal of Infection and Chemotherapy;2024-08

2. Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series;Infection;2024-07-19

3. Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review;Chemotherapy;2023-11-14

4. An Unexpected Turn of Events in a Patient With Mitral Valve Endocarditis;Cureus;2023-07-19

5. Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections;Clinical Microbiology Reviews;2023-06-21